IL-33 stimulates conventional Th2 cells to release IL-4, IL-5, and IL-13 and IL-33-driven Th2 cells profoundly inhibit atherosclerosis (Miller et al., 2008). The gene discussed is IL33; the disease is atherosclerosis.